Workload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study.

addiction direct observed therapy health app mHealth methadone mobile app mobile health opioid smartphone app substance use usability user engagement user testing workload

Journal

JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561

Informations de publication

Date de publication:
13 Jul 2023
Historique:
received: 26 09 2022
accepted: 25 05 2023
revised: 02 05 2023
medline: 13 7 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Methadone, a cornerstone of opioid use disorder treatments for many decades, is an essential tool for combatting the opioid epidemic. However, requirements for observing methadone dosing in person through direct observed therapy (DOT) impose significant barriers for many patients. Digital technology can facilitate remote DOT, which could reduce barriers to methadone treatment. Currently, there are limited data on the usability of such technology among patients and counselors in methadone treatment settings. The primary objective of this study was to assess the workload, usability, and engagement of a video-based DOT mobile app for patients with opioid use disorder receiving methadone treatment. The secondary objective was to assess the workload, usability, and engagement of the provider-facing app portal used by counselors. Patients (n=12) and counselors (n=3) who previously tried video DOT for methadone through a smartphone app in an opioid treatment program participated in usability testing sessions. Participants completed essential tasks for video DOT, then provided ratings of workload (NASA Task Load Index), usability (modified System Usability Scale), and engagement (modified Engagement Scale) with the core features of the video DOT program. Patients and counselors reported low mental, physical, and temporal demands, successful performance, low effort, and low frustration associated with activities. Patients reported high usability (mean 85, SD 9.5) and engagement (mean 3.8, SD 1.1); counselors reported moderate usability (mean 43.3, SD 17.7) and engagement (mean 2.81, SD 0.63). A mobile health app that facilitates video-based DOT for methadone required a low workload for patients and counselors and was highly usable for patients in an opioid treatment program; however, there are opportunities to improve usability and engagement for the counselor-facing portal.

Sections du résumé

BACKGROUND BACKGROUND
Methadone, a cornerstone of opioid use disorder treatments for many decades, is an essential tool for combatting the opioid epidemic. However, requirements for observing methadone dosing in person through direct observed therapy (DOT) impose significant barriers for many patients. Digital technology can facilitate remote DOT, which could reduce barriers to methadone treatment. Currently, there are limited data on the usability of such technology among patients and counselors in methadone treatment settings.
OBJECTIVE OBJECTIVE
The primary objective of this study was to assess the workload, usability, and engagement of a video-based DOT mobile app for patients with opioid use disorder receiving methadone treatment. The secondary objective was to assess the workload, usability, and engagement of the provider-facing app portal used by counselors.
METHODS METHODS
Patients (n=12) and counselors (n=3) who previously tried video DOT for methadone through a smartphone app in an opioid treatment program participated in usability testing sessions. Participants completed essential tasks for video DOT, then provided ratings of workload (NASA Task Load Index), usability (modified System Usability Scale), and engagement (modified Engagement Scale) with the core features of the video DOT program.
RESULTS RESULTS
Patients and counselors reported low mental, physical, and temporal demands, successful performance, low effort, and low frustration associated with activities. Patients reported high usability (mean 85, SD 9.5) and engagement (mean 3.8, SD 1.1); counselors reported moderate usability (mean 43.3, SD 17.7) and engagement (mean 2.81, SD 0.63).
CONCLUSIONS CONCLUSIONS
A mobile health app that facilitates video-based DOT for methadone required a low workload for patients and counselors and was highly usable for patients in an opioid treatment program; however, there are opportunities to improve usability and engagement for the counselor-facing portal.

Identifiants

pubmed: 37440298
pii: v10i1e42654
doi: 10.2196/42654
pmc: PMC10375394
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e42654

Subventions

Organisme : NIAAA NIH HHS
ID : K01 AA024796
Pays : United States
Organisme : NIDA NIH HHS
ID : R41 DA053081
Pays : United States

Informations de copyright

©Bulat Idrisov, Kevin A Hallgren, Alyssa Michaels, Sean Soth, James Darnton, Paul Grekin, Steve Woolworth, Andrew J Saxon, Judith I Tsui. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 13.07.2023.

Références

JAMA Netw Open. 2018 Jun 1;1(2):e180217
pubmed: 30646062
J Med Internet Res. 2020 Jun 2;22(6):e18073
pubmed: 32348292
Psychiatr Serv. 2022 May;73(5):484-491
pubmed: 34644125
J Subst Abuse Treat. 2022 Dec;143:108896
pubmed: 36215911

Auteurs

Bulat Idrisov (B)

Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States.

Kevin A Hallgren (KA)

Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.

Alyssa Michaels (A)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Sean Soth (S)

Evergreen Treatment Services, Seattle, WA, United States.

James Darnton (J)

Evergreen Treatment Services, Seattle, WA, United States.
Division of General Internal Medicine, University of Washington, Seattle, WA, United States.

Paul Grekin (P)

Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.
Evergreen Treatment Services, Seattle, WA, United States.

Steve Woolworth (S)

Evergreen Treatment Services, Seattle, WA, United States.

Andrew J Saxon (AJ)

Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.
Center of Excellence in Substance Addiction Treatment and Education, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States.

Judith I Tsui (JI)

Division of General Internal Medicine, University of Washington, Seattle, WA, United States.

Classifications MeSH